1tuf

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1tuf" size="450" color="white" frame="true" align="right" spinBox="true" caption="1tuf, resolution 2.40&Aring;" /> '''Crystal structure of...)
Line 1: Line 1:
-
[[Image:1tuf.gif|left|200px]]<br /><applet load="1tuf" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1tuf.gif|left|200px]]<br /><applet load="1tuf" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1tuf, resolution 2.40&Aring;" />
caption="1tuf, resolution 2.40&Aring;" />
'''Crystal structure of Diaminopimelate Decarboxylase from m. jannaschi'''<br />
'''Crystal structure of Diaminopimelate Decarboxylase from m. jannaschi'''<br />
==Overview==
==Overview==
-
Cocrystal structures of Methanococcus jannaschii diaminopimelate, decarboxylase (DAPDC) bound to a substrate analog, azelaic acid, and its, L-lysine product have been determined at 2.6 A and 2.0 A, respectively., This PLP-dependent enzyme is responsible for the final step of L-lysine, biosynthesis in bacteria and plays a role in beta-lactam antibiotic, resistance in Staphylococcus aureus. Substrate specificity derives from, recognition of the L-chiral center of diaminopimelate and a system of, ionic "molecular rulers" that dictate substrate length. A coupled-enzyme, assay system permitted measurement of kinetic parameters for recombinant, DAPDCs and inhibition constants (K(i)) for azelaic acid (89 microM) and, other substrate analogs. Implications for rational design of, broad-spectrum antimicrobial agents targeted against DAPDCs of, drug-resistant strains of bacterial pathogens, such as Staphylococcus, aureus, are discussed.
+
Cocrystal structures of Methanococcus jannaschii diaminopimelate decarboxylase (DAPDC) bound to a substrate analog, azelaic acid, and its L-lysine product have been determined at 2.6 A and 2.0 A, respectively. This PLP-dependent enzyme is responsible for the final step of L-lysine biosynthesis in bacteria and plays a role in beta-lactam antibiotic resistance in Staphylococcus aureus. Substrate specificity derives from recognition of the L-chiral center of diaminopimelate and a system of ionic "molecular rulers" that dictate substrate length. A coupled-enzyme assay system permitted measurement of kinetic parameters for recombinant DAPDCs and inhibition constants (K(i)) for azelaic acid (89 microM) and other substrate analogs. Implications for rational design of broad-spectrum antimicrobial agents targeted against DAPDCs of drug-resistant strains of bacterial pathogens, such as Staphylococcus aureus, are discussed.
==About this Structure==
==About this Structure==
-
1TUF is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Methanocaldococcus_jannaschii Methanocaldococcus jannaschii] with AZ1 as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Diaminopimelate_decarboxylase Diaminopimelate decarboxylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.1.1.20 4.1.1.20] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1TUF OCA].
+
1TUF is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Methanocaldococcus_jannaschii Methanocaldococcus jannaschii] with <scene name='pdbligand=AZ1:'>AZ1</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Diaminopimelate_decarboxylase Diaminopimelate decarboxylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.1.1.20 4.1.1.20] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TUF OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Methanocaldococcus jannaschii]]
[[Category: Methanocaldococcus jannaschii]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Bonanno, J.B.]]
+
[[Category: Bonanno, J B.]]
-
[[Category: Burley, S.K.]]
+
[[Category: Burley, S K.]]
[[Category: He, G.]]
[[Category: He, G.]]
-
[[Category: Lencastre, H.De.]]
+
[[Category: Lencastre, H De.]]
-
[[Category: NYSGXRC, New.York.Structural.GenomiX.Research.Consortium.]]
+
[[Category: NYSGXRC, New York Structural GenomiX Research Consortium.]]
-
[[Category: Pinho, M.G.]]
+
[[Category: Pinho, M G.]]
[[Category: Rajashankar, K.]]
[[Category: Rajashankar, K.]]
-
[[Category: Ray, S.R.]]
+
[[Category: Ray, S R.]]
[[Category: Tomasz, A.]]
[[Category: Tomasz, A.]]
[[Category: AZ1]]
[[Category: AZ1]]
Line 34: Line 34:
[[Category: t135]]
[[Category: t135]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 03:36:03 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:17:26 2008''

Revision as of 13:17, 21 February 2008


1tuf, resolution 2.40Å

Drag the structure with the mouse to rotate

Crystal structure of Diaminopimelate Decarboxylase from m. jannaschi

Overview

Cocrystal structures of Methanococcus jannaschii diaminopimelate decarboxylase (DAPDC) bound to a substrate analog, azelaic acid, and its L-lysine product have been determined at 2.6 A and 2.0 A, respectively. This PLP-dependent enzyme is responsible for the final step of L-lysine biosynthesis in bacteria and plays a role in beta-lactam antibiotic resistance in Staphylococcus aureus. Substrate specificity derives from recognition of the L-chiral center of diaminopimelate and a system of ionic "molecular rulers" that dictate substrate length. A coupled-enzyme assay system permitted measurement of kinetic parameters for recombinant DAPDCs and inhibition constants (K(i)) for azelaic acid (89 microM) and other substrate analogs. Implications for rational design of broad-spectrum antimicrobial agents targeted against DAPDCs of drug-resistant strains of bacterial pathogens, such as Staphylococcus aureus, are discussed.

About this Structure

1TUF is a Single protein structure of sequence from Methanocaldococcus jannaschii with as ligand. Active as Diaminopimelate decarboxylase, with EC number 4.1.1.20 Full crystallographic information is available from OCA.

Reference

Cocrystal structures of diaminopimelate decarboxylase: mechanism, evolution, and inhibition of an antibiotic resistance accessory factor., Ray SS, Bonanno JB, Rajashankar KR, Pinho MG, He G, De Lencastre H, Tomasz A, Burley SK, Structure. 2002 Nov;10(11):1499-508. PMID:12429091

Page seeded by OCA on Thu Feb 21 15:17:26 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools